T. Barnes

1.5k citations

28 papers · 988 indexed · h-index 12

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Cancer Research

Papers in

Cancer Research 9
- Cancer Genomics and Diagnostics 7
Oncology 13
- Lung Cancer Research Studies 4

Co-authors: Eitan Amir Boštjan Šeruga Alberto Ocaña Grainne M. O’Kane Hadar Goldvaser Domen Ribnikar David W. Cescon Stephen Clarke
Journals: Journal of Thoracic Oncology (3 papers)Journal of Clinical Oncology (3 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)The Oncologist (2 papers)Supportive Care in Cancer (2 papers)
Partner nations: Canada Australia United States

In The Last Decade

T. Barnes

28 papers receiving 972 citations

Peers

Countries citing papers authored by T. Barnes

Since Specialization

Citations

This map shows the geographic impact of T. Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Barnes more than expected).

Fields of papers citing papers by T. Barnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Barnes. The network helps show where T. Barnes may publish in the future.

Co-authors

The 25 scholars most cited alongside T. Barnes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T. Barnes Line = papers co-authored together T. Barnes links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Telehealth cognitive behaviour therapy for the management of sleep disturbance in women with early breast cancer receiving chemotherapy: a feasibility study Supportive Care in Cancer ·苗云鹏, Haryana M. Dhillon, Janette L. Vardy, Chris Brown, О. П. Ведьмин, Stephen Della‐Fiorentina, Sarah Khan, Md. Muyeed Hasan, A A Vahdi, A. Scott Pearson, T. Barnes, Belinda E. Kiely	2024	1
2	The Perceived Value of Liquid Biopsy: Results From a Canadian Validation Study of Circulating Tumor DNA T790M Testing—Patient’s Willingness-to-Pay: A Brief Report JTO Clinical and Research Reports ·Babak Mikaeeli Kangarshahi, T. Barnes, Janessa Laskin, Parneet Cheema, Geoffrey Liu, Mussawar Iqbal, J. Rothenstein, Ronald L. Burkes, Ming‐Sound Tsao, Natasha B. Leighl	2023	1
3	Can Oncologists Predict the Efficacy of Treatments in Randomized Trials? The Oncologist ·D. M. Benjamin, David R. Mandel, T. Barnes, Monika K. Krzyzanowska, Natasha B. Leighl, Ian F. Tannock, Jonathan Kimmelman	2020	10
4	Rapid Access Palliative Radiotherapy Programmes Clinical Oncology ·Kristopher Dennis, 张颂恩 Teo, Rasha Kamel, T. Barnes, Tracy A. Balboni, Paul Fenton, Agata Rembielak	2020	22
5	Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience The Oncologist ·Hamzeh Albaba, T. Barnes, Zachary Veitch, M. Catherine Brown, Diarmuid Ó Seanacháin Dálaigh, Susie Su, Hiten Naik, 隆雄室, Magdalena Raszka, A. A. Beekman, Lawson Eng, Nicole Mittmann, Wei Xu, Doris Howell, Geoffrey Liu	2019	17
6	Efficacy, safety, tolerability and price of newly approved drugs in solid tumors Cancer Treatment Reviews ·T. Barnes, Eitan Amir, Arnoud J. Templeton, Annabelle Malins, Beatriz Navarro Bravo, Boštjan Šeruga, Alberto Ocaña	2017	38
7	HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer British Journal of Cancer ·T. Barnes, Eitan Amir	2017	320
8	Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance Theranostics ·J Evan, Nick Pavlakis, Geoffrey Schembri, Elizabeth J. Bernard, Edward Hsiao, Aimee R. Hayes, T. Barnes, Connie I. Diakos, Mustafa Khasraw, Jaswinder S. Samra, Enid M. Eslick, Paul Roach, Alexander Engel, Stephen Clarke, Dale L. Bailey	2017	208
9	Toxicity of Extended Adjuvant Therapy With Aromatase Inhibitors in Early Breast Cancer: A Systematic Review and Meta-analysis JNCI Journal of the National Cancer Institute ·Hadar Goldvaser, T. Barnes, Boštjan Šeruga, David W. Cescon, Alberto Ocaña, Domen Ribnikar, Eitan Amir	2017	123
10	Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer Frontiers in Oncology ·T. Barnes, Grainne M. O’Kane, Mark Vincent, Rohit Khare	2017	50
11	Afatinib in patients with metastatic HER2-mutant lung cancers: An international multicenter study. Journal of Clinical Oncology ·木子崔, Henry Duncan Skrine, Julie Milia, T. Barnes, Oliver Gautschi, Solange Peters, Roberto Ferrara, Ai Ni, Joshua K. Sabari, Stephen Clarke, Nick Pavlakis, Charles M. Rudin, Maria E. Arcila, Natasha B. Leighl, Frances A. Shepherd, Mark G. Kris, Julien Mazières, Bob T. Li	2017	12
12	Toxicity of extended adjuvant aromatase inhibitors therapy in postmenopausal breast cancer patients: A systematic review and meta-analysis. Journal of Clinical Oncology ·Hadar Goldvaser, Domen Ribnikar, T. Barnes, David W. Cescon, Alberto Ocaña, Eitan Amir	2017	3
13	Efficacy, safety, tolerability and price of newly approved drugs in solid tumors. Journal of Clinical Oncology ·T. Barnes, Eitan Amir, Arnoud J. Templeton, 崔基贤, Beatriz Navarro Bravo, Boštjan Šeruga, Alberto Ocaña	2017	4
14	P3.01-062 The Perceived Value of Avoiding Biopsy: Patients' Willingness to Pay for Circulating Tumor DNA T790M Testing Journal of Thoracic Oncology ·T. Barnes, Janessa Laskin, Parneet Cheema, G. Liu, B. Franek, J. Rothenstein, R. Burkes, Scott Owen, Laura G. Dunson Caputo, 정유창, P. Antony Seba, Lindsay M. Wong, T. Trziszka, HU Li-li, Ming‐Sound Tsao, N. B. Leighl	2017	1
15	The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials Lung Cancer ·Bob T. Li, T. Barnes, David Chan, Jarushka Naidoo, C Calvié, Mustafa Khasraw, Gavin Marx, Mark G. Kris, Stephen Clarke, Alexander Drilon, Charles M. Rudin, Nick Pavlakis	2016	10
16	Dual 18F-fluorodeoxyglucose/68Gallium DOTATATE (FDG/DOTA) PET grading and histological grade in neuroendocrine tumours (NET) Figshare ·David Chan, Dale L. Bailey, Geoffrey Schembri, Elizabeth J. Bernard, Edward Hsiao, T. Barnes, Connie I. Diakos, Stephen Clarke, Mustafa Khasraw, Vilhelm Moberg, Nick Pavlakis, Paul Roach	2016	1
17	Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report Molecular and Clinical Oncology ·David Chan, Stephen Clarke, Anthony J. Gill, Lorraine A. Chantrill, Vilhelm Moberg, Bob T. Li, T. Barnes, Aline N'CHO, Nick Pavlakis	2015	8
18	Beryllium-Induced TNF-α Production Is Transcription-Dependent in Chronic Beryllium Disease American Journal of Respiratory Cell and Molecular Biology ·Richard T. Sawyer, Andrew P. Fontenot, T. Barnes, 和樹森田, Carol Chapman, Lisa A. Maier, Katharine Knappenberger, 袁磊, Lori Silveira, James Hagman, Lee S. Newman	2006	11
19	An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy Supportive Care in Cancer ·Cyril Danjoux, Edward Chow, Juha Nyberg, L. Holden, Charles Hayter, May Tsao, T. Barnes, Emily Sinclair, Kimberly Hartnett	2005	74
20	Regional mapping of the gene encoding dihydroorotate dehydrogenase, an enzyme involved in UMP synthesis, electron transport, and superoxide generation, to human chromosome region 16q22 Somatic Cell and Molecular Genetics ·T. Barnes, Teresa Bastos, Iris Hart, Carol Jones, Michèle Minét, David Patterson	1993	20

About T. Barnes

T. Barnes is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiation and Otorhinolaryngology, having authored 28 papers that have together received 988 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (8 papers), Cancer Genomics and Diagnostics (7 papers), Lung Cancer Research Studies (4 papers), Management of metastatic bone disease (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Advanced Radiotherapy Techniques (3 papers), Economic and Financial Impacts of Cancer (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). The work is most often cited by research in Oncology (610 citations), Cancer Research (157 citations), Neurology (153 citations), Immunology (176 citations) and Pulmonary and Respiratory Medicine (256 citations). T. Barnes has collaborated with scholars based in Canada, Australia and United States. Frequent co-authors include Eitan Amir, Boštjan Šeruga, Alberto Ocaña, Grainne M. O’Kane, Hadar Goldvaser, Domen Ribnikar, David W. Cescon, Stephen Clarke, Nick Pavlakis and Mustafa Khasraw. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, The Oncologist and Supportive Care in Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact